West Pharmaceutical Services Inc
WST· NYSE
Released Apr 24, 2025, before the open
10-Q filed Apr 24, 2025, 24 days after period end · 0000105770-25-000036
| Metric | Q1 2025 | Q1 2024 | Q1 2023 | Q1 2022 |
|---|---|---|---|---|
| Revenue | $698.00M | $695.40M | $716.60M | $720.00M |
| Net Income | $89.80M | $115.30M | $140.00M | $173.80M |
| EPS Diluted |
West Pharmaceutical Services Inc · CIK 105770 · Engraved from SEC EDGAR
| $1.23 |
| $1.55 |
| $1.85 |
| $2.29 |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.